{"id":485,"date":"2021-04-20T11:49:00","date_gmt":"2021-04-20T09:49:00","guid":{"rendered":"https:\/\/www.dkcommunications.de\/en\/?p=485"},"modified":"2025-10-28T12:12:07","modified_gmt":"2025-10-28T11:12:07","slug":"expertise-in-rare-diseases","status":"publish","type":"post","link":"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/","title":{"rendered":"Expertise in rare diseases"},"content":{"rendered":"\n<p>Here are the indications in full: Alpha-1 antitrypsin deficiency (A1AT deficiency), achondroplasia (ACH), acquired thrombotic thrombocytopenic purpura (aTTP), cold aglutinin disease (CAD), chronic inflammatory demyelinating polyneuropathy (CIDP), late infantile neuronal ceroid lipofuscinosis (CLN2), Duchenne muscular dystrophy with nonsense mutation (DMD NM), hereditary angioedema (HAE), Fabry disease, Gaucher disease, Pompe disease, mucopolysaccharidoses (MPS), lung disease caused by non-tuberculous mycobacteria (NTM-LD), phenylketonuria (PKU), primary immunodeficiencies (PDI), secondary immunodeficiencies (SID). Learn more about our expertise on orphan drugs and give us a call.<\/p>\n\n\n\n<p><strong>Want to see the whole ad?<br>Please click on <a href=\"\/\/file?uid=408\" target=\"_blank\" rel=\"noreferrer noopener\">image ad<\/a>.<\/strong><\/p>\n\n\n\n<p>Here you can order the <a href=\"https:\/\/www.healthcaremarketing.eu\/einzelnexp\/index.php?Ausgabe=Ausgabe%20Markenf%FChrung%20Orphan%20Drugs\" target=\"_blank\" rel=\"noreferrer noopener\">special &#8220;Brand Management for Orphan Drugs&#8221;<\/a> from Healthcare Marketing.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Our new corporate image ad focuses on our diverse expertise in rare disease communications. Published in Healthcare Marketing&#8217;s special &#8220;Brand management for Orphan Drugs.&#8221;<\/p>\n","protected":false},"author":1,"featured_media":486,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-485","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Expertise in rare diseases - dk Life Science Communications<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Expertise in rare diseases - dk Life Science Communications\" \/>\n<meta property=\"og:description\" content=\"Our new corporate image ad focuses on our diverse expertise in rare disease communications. Published in Healthcare Marketing&#039;s special &quot;Brand management for Orphan Drugs.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"dk Life Science Communications\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-20T09:49:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T11:12:07+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2024\/05\/DK_Anzeige_2021_Orphan_Drugs_News-Bild_2436x3856px-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1617\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"n.mueck\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"n.mueck\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/\",\"url\":\"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/\",\"name\":\"Expertise in rare diseases - dk Life Science Communications\",\"isPartOf\":{\"@id\":\"https:\/\/www.dkcommunications.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2024\/05\/DK_Anzeige_2021_Orphan_Drugs_News-Bild_2436x3856px-scaled.jpg\",\"datePublished\":\"2021-04-20T09:49:00+00:00\",\"dateModified\":\"2025-10-28T11:12:07+00:00\",\"author\":{\"@id\":\"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/036d0d9f1b8c99079aac1a8c4b3d8dea\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/#primaryimage\",\"url\":\"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2024\/05\/DK_Anzeige_2021_Orphan_Drugs_News-Bild_2436x3856px-scaled.jpg\",\"contentUrl\":\"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2024\/05\/DK_Anzeige_2021_Orphan_Drugs_News-Bild_2436x3856px-scaled.jpg\",\"width\":2560,\"height\":1617},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.dkcommunications.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Expertise in rare diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/#website\",\"url\":\"https:\/\/www.dkcommunications.de\/en\/\",\"name\":\"dk Life Science Communications\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.dkcommunications.de\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/036d0d9f1b8c99079aac1a8c4b3d8dea\",\"name\":\"n.mueck\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1d9d94bfe0b9469a4186c26da428d936?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1d9d94bfe0b9469a4186c26da428d936?s=96&d=mm&r=g\",\"caption\":\"n.mueck\"},\"sameAs\":[\"http:\/\/www.dkcommunications.de\"],\"url\":\"https:\/\/www.dkcommunications.de\/en\/blog\/author\/n-mueck\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Expertise in rare diseases - dk Life Science Communications","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/","og_locale":"en_US","og_type":"article","og_title":"Expertise in rare diseases - dk Life Science Communications","og_description":"Our new corporate image ad focuses on our diverse expertise in rare disease communications. Published in Healthcare Marketing's special \"Brand management for Orphan Drugs.\"","og_url":"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/","og_site_name":"dk Life Science Communications","article_published_time":"2021-04-20T09:49:00+00:00","article_modified_time":"2025-10-28T11:12:07+00:00","og_image":[{"width":2560,"height":1617,"url":"http:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2024\/05\/DK_Anzeige_2021_Orphan_Drugs_News-Bild_2436x3856px-scaled.jpg","type":"image\/jpeg"}],"author":"n.mueck","twitter_card":"summary_large_image","twitter_misc":{"Written by":"n.mueck","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/","url":"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/","name":"Expertise in rare diseases - dk Life Science Communications","isPartOf":{"@id":"https:\/\/www.dkcommunications.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/#primaryimage"},"image":{"@id":"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2024\/05\/DK_Anzeige_2021_Orphan_Drugs_News-Bild_2436x3856px-scaled.jpg","datePublished":"2021-04-20T09:49:00+00:00","dateModified":"2025-10-28T11:12:07+00:00","author":{"@id":"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/036d0d9f1b8c99079aac1a8c4b3d8dea"},"breadcrumb":{"@id":"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/#primaryimage","url":"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2024\/05\/DK_Anzeige_2021_Orphan_Drugs_News-Bild_2436x3856px-scaled.jpg","contentUrl":"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2024\/05\/DK_Anzeige_2021_Orphan_Drugs_News-Bild_2436x3856px-scaled.jpg","width":2560,"height":1617},{"@type":"BreadcrumbList","@id":"https:\/\/www.dkcommunications.de\/en\/blog\/expertise-in-rare-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.dkcommunications.de\/en\/"},{"@type":"ListItem","position":2,"name":"Expertise in rare diseases"}]},{"@type":"WebSite","@id":"https:\/\/www.dkcommunications.de\/en\/#website","url":"https:\/\/www.dkcommunications.de\/en\/","name":"dk Life Science Communications","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dkcommunications.de\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/036d0d9f1b8c99079aac1a8c4b3d8dea","name":"n.mueck","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1d9d94bfe0b9469a4186c26da428d936?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1d9d94bfe0b9469a4186c26da428d936?s=96&d=mm&r=g","caption":"n.mueck"},"sameAs":["http:\/\/www.dkcommunications.de"],"url":"https:\/\/www.dkcommunications.de\/en\/blog\/author\/n-mueck\/"}]}},"_links":{"self":[{"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/posts\/485"}],"collection":[{"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/comments?post=485"}],"version-history":[{"count":3,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/posts\/485\/revisions"}],"predecessor-version":[{"id":675,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/posts\/485\/revisions\/675"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/media\/486"}],"wp:attachment":[{"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/media?parent=485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/categories?post=485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/tags?post=485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}